KTC
ELV icon

Kistler-Tiffany Companies’s Elevance Health ELV Stock Holding History

Kistler-Tiffany Companies’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$6.67K Sell
15
-10
-40% -$4.61K ﹤0.01% 738
2023
Q1 		$11.5K Sell
25
-76
-75% -$36.2K ﹤0.01% 620
2022
Q4 		$51.8K Sell
101
-52
-34% -$26.4K 0.01% 413
2022
Q3 		$69K Hold
153
– – 0.02% 334
2022
Q2 		$74K Buy
153
+22
+17% +$10.9K 0.02% 326
2022
Q1 		$64K Buy
+131
New +$59.9K 0.01% 362

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Kistler-Tiffany Companies's ELV Position: Q2 2023 in Review

Kistler-Tiffany Companies reduced its Elevance Health (ELV) stake by 40% in Q2 2023, selling an estimated $4.61K and leaving 15 shares worth $6.67K. The position accounts for ﹤0.01% of the portfolio, ranked #738.

Kistler-Tiffany Companies first reported a position in ELV in Q1 2022 and has held it in 6 quarters since. The position peaked at $74K in Q2 2022. 1,524 funds tracked by Wall St. Rank hold ELV as of Q2 2023.

  • Kistler-Tiffany Companies held 15 shares of Elevance Health worth $6.67K as of Q2 2023.
  • Kistler-Tiffany Companies sold 10 Elevance Health shares in Q2 2023, an estimated $4.61K.
  • Elevance Health made up ﹤0.01% of Kistler-Tiffany Companies's portfolio in Q2 2023, its #738 holding.
  • Kistler-Tiffany Companies first reported a position in Elevance Health in Q1 2022 and has held it in 6 quarters since.
  • Kistler-Tiffany Companies's Elevance Health position peaked at $74K in Q2 2022.
  • 1,524 funds tracked by Wall St. Rank held Elevance Health as of Q2 2023.

Based on Kistler-Tiffany Companies's 13F filing for Q2 2023, filed 1 Aug 2023.